Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
Evidence shows that the endocannabinoid system modulates the addictive properties of nicotine. In the present study, we hypothesized that spontaneous withdrawal resulting from removal of chronically implanted transdermal nicotine patches is regulated by the endocannabinoid system. A 7-day nicotine d...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3227620?pdf=render |
id |
doaj-9919a6d6605546feb5537f933b7256e1 |
---|---|
record_format |
Article |
spelling |
doaj-9919a6d6605546feb5537f933b7256e12020-11-24T22:00:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01611e2814210.1371/journal.pone.0028142Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.Andrea CippitelliGiuseppe AstaritaAndrea DurantiGiovanni CaprioliMassimo UbaldiSerena StopponiMarsida KallupiGianni SagratiniFernando Rodrìguez de FonsecaDaniele PiomelliRoberto CiccocioppoEvidence shows that the endocannabinoid system modulates the addictive properties of nicotine. In the present study, we hypothesized that spontaneous withdrawal resulting from removal of chronically implanted transdermal nicotine patches is regulated by the endocannabinoid system. A 7-day nicotine dependence procedure (5.2 mg/rat/day) elicited occurrence of reliable nicotine abstinence symptoms in Wistar rats. Somatic and affective withdrawal signs were observed at 16 and 34 hours following removal of nicotine patches, respectively. Further behavioral manifestations including decrease in locomotor activity and increased weight gain also occurred during withdrawal. Expression of spontaneous nicotine withdrawal was accompanied by fluctuation in levels of the endocannabinoid anandamide (AEA) in several brain structures including the amygdala, the hippocampus, the hypothalamus and the prefrontal cortex. Conversely, levels of 2-arachidonoyl-sn-glycerol were not significantly altered. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for the intracellular degradation of AEA, by URB597 (0.1 and 0.3 mg/kg, i.p.), reduced withdrawal-induced anxiety as assessed by the elevated plus maze test and the shock-probe defensive burying paradigm, but did not prevent the occurrence of somatic signs. Together, the results indicate that pharmacological strategies aimed at enhancing endocannabinoid signaling may offer therapeutic advantages to treat the negative affective state produced by nicotine withdrawal, which is critical for the maintenance of tobacco use.http://europepmc.org/articles/PMC3227620?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrea Cippitelli Giuseppe Astarita Andrea Duranti Giovanni Caprioli Massimo Ubaldi Serena Stopponi Marsida Kallupi Gianni Sagratini Fernando Rodrìguez de Fonseca Daniele Piomelli Roberto Ciccocioppo |
spellingShingle |
Andrea Cippitelli Giuseppe Astarita Andrea Duranti Giovanni Caprioli Massimo Ubaldi Serena Stopponi Marsida Kallupi Gianni Sagratini Fernando Rodrìguez de Fonseca Daniele Piomelli Roberto Ciccocioppo Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. PLoS ONE |
author_facet |
Andrea Cippitelli Giuseppe Astarita Andrea Duranti Giovanni Caprioli Massimo Ubaldi Serena Stopponi Marsida Kallupi Gianni Sagratini Fernando Rodrìguez de Fonseca Daniele Piomelli Roberto Ciccocioppo |
author_sort |
Andrea Cippitelli |
title |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. |
title_short |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. |
title_full |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. |
title_fullStr |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. |
title_full_unstemmed |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. |
title_sort |
endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of faah inhibition. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2011-01-01 |
description |
Evidence shows that the endocannabinoid system modulates the addictive properties of nicotine. In the present study, we hypothesized that spontaneous withdrawal resulting from removal of chronically implanted transdermal nicotine patches is regulated by the endocannabinoid system. A 7-day nicotine dependence procedure (5.2 mg/rat/day) elicited occurrence of reliable nicotine abstinence symptoms in Wistar rats. Somatic and affective withdrawal signs were observed at 16 and 34 hours following removal of nicotine patches, respectively. Further behavioral manifestations including decrease in locomotor activity and increased weight gain also occurred during withdrawal. Expression of spontaneous nicotine withdrawal was accompanied by fluctuation in levels of the endocannabinoid anandamide (AEA) in several brain structures including the amygdala, the hippocampus, the hypothalamus and the prefrontal cortex. Conversely, levels of 2-arachidonoyl-sn-glycerol were not significantly altered. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for the intracellular degradation of AEA, by URB597 (0.1 and 0.3 mg/kg, i.p.), reduced withdrawal-induced anxiety as assessed by the elevated plus maze test and the shock-probe defensive burying paradigm, but did not prevent the occurrence of somatic signs. Together, the results indicate that pharmacological strategies aimed at enhancing endocannabinoid signaling may offer therapeutic advantages to treat the negative affective state produced by nicotine withdrawal, which is critical for the maintenance of tobacco use. |
url |
http://europepmc.org/articles/PMC3227620?pdf=render |
work_keys_str_mv |
AT andreacippitelli endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT giuseppeastarita endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT andreaduranti endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT giovannicaprioli endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT massimoubaldi endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT serenastopponi endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT marsidakallupi endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT giannisagratini endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT fernandorodriguezdefonseca endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT danielepiomelli endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition AT robertociccocioppo endocannabinoidregulationofacuteandprotractednicotinewithdrawaleffectoffaahinhibition |
_version_ |
1725845159729430528 |